|
Age-sex group
|
Estimated population
|
Estimated number of infected children
|
Lower 95% BCI*
|
Upper 95% BCI*
|
Model based prevalence
|
Model-based population adjusted prevalence
|
|---|
|
a) Plasmodium sp.
| | | | | | |
|
Boys 5-9 yrs
|
1,966,324
|
927,634
|
337,740
|
1,547,775
|
47.7% (4.5)
|
47.2%
|
|
Boys 10-14 yrs
|
1,587,915
|
607,356
|
190,873
|
1,128,372
|
38.8% (4.3)
|
38.2%
|
|
Boys 14-19 yrs
|
1,268,729
|
431,452
|
125,464
|
848,679
|
34.6% (4.1)
|
34.0%
|
|
Girls 5-9 yrs
|
1,956,764
|
607,291
|
163,873
|
1,252,415
|
31.5% (3.5)
|
31.0%
|
|
Girls 10-14 yrs
|
1,576,155
|
372,161
|
90,670
|
852,659
|
24.1% (3.3)
|
23.6%
|
|
Girls 14-19 yrs
|
1,247,670
|
254,625
|
55,329
|
614,181
|
21.0% (3.0)
|
20.4%
|
|
TOTAL
|
9,603,557
|
3,200,519
|
963,949
|
6,244,081
|
33.0%
|
33.3%
|
|
b)
W. bancrofti
| | | | | | |
|
5-9 yrs
|
3,923,088
|
170,668
|
5,027
|
691,754
|
6.7%
|
4.4%
|
|
10-14 yrs
|
3,164,070
|
202,885
|
8,416
|
733,247
|
9.3%
|
6.4%
|
|
14-19 yrs
|
2,516,399
|
180,860
|
7,893
|
665,842
|
10.1%
|
7.2%
|
|
TOTAL
|
9,603,557
|
554,413
|
21,336
|
2,090,843
|
8.7%
|
6.0%
|
- * Bayesian credible interval
